Balyasny Asset Management LLC Tandem Diabetes Care Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$30.43 - $53.43 $6.87 Million - $12.1 Million	-225,891 Reduced 96.32%	8,629 $347,000
Q1 2024 May 13, 2024	BUY	$22.09 - $35.41 $2.83 Million - $4.54 Million	128,111 Added 120.39%	234,520 $8.3 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $1.52 Million - $3.3 Million	106,409 New	106,409 $3.15 Million
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $10.8 Million - $14 Million	-300,703 Reduced 51.77%	280,192 $11.4 Million
Q4 2022 Feb 14, 2023	BUY	$35.49 - $56.15 $10.2 Million - $16.1 Million	287,375 Added 97.91%	580,895 $26.1 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $12.8 Million - $20.2 Million	293,520 New	293,520 $14 Million
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $5.48 Million - $12.7 Million	-102,891 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$101.89 - $150.09 $6.99 Million - $10.3 Million	-68,587 Reduced 40.0%	102,891 $12 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $20.3 Million - $26.3 Million	171,478 New	171,478 $25.8 Million
Q4 2020 Feb 16, 2021	SELL	$86.4 - $121.75 $24.7 Million - $34.8 Million	-285,720 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $12.5 Million - $15.2 Million	131,026 Added 84.7%	285,720 $32.4 Million
Q2 2020 Aug 14, 2020	SELL	$60.05 - $98.92 $171,082 - $281,823	-2,849 Reduced 1.81%	154,694 $15.3 Million
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $11.9 Million - $22.6 Million	-251,471 Reduced 61.48%	157,543 $10.1 Million
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $10.2 Million - $13.6 Million	191,161 Added 87.75%	409,014 $24.4 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $2.24 Million - $2.88 Million	-39,240 Reduced 15.26%	217,853 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $13.8 Million - $18.1 Million	252,928 Added 6072.7%	257,093 $16.6 Million
Q1 2019 May 15, 2019	SELL	$32.25 - $73.56 $2.65 Million - $6.05 Million	-82,270 Reduced 95.18%	4,165 $264,000
Q4 2018 Feb 14, 2019	BUY	$28.45 - $40.65 $781,293 - $1.12 Million	27,462 Added 46.57%	86,435 $3.28 Million
Q3 2018 Nov 14, 2018	SELL	$21.39 - $51.17 $7.62 Million - $18.2 Million	-356,027 Reduced 85.79%	58,973 $2.53 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $624,750 - $3.01 Million	127,500 Added 44.35%	415,000 $9.14 Million
Q1 2018 May 15, 2018	BUY	$2.35 - $4.96 $675,625 - $1.43 Million	287,500 New	287,500 $1.43 Million

Others Institutions Holding TNDM

# of Institutions

359

Shares Held

72.2M

Call Options Held

3.36M

Put Options Held

229K

Black Rock Inc. New York, NY

11.1M
Shares

$410 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.36M
Shares

$271 Million
0.01% of portfolio
Capital World Investors Los Angeles, CA

3.27M
Shares

$120 Million
0.02% of portfolio
State Street Corp Boston, MA

2.66M
Shares

$97.8 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

2.39M
Shares

$87.9 Million
1.44% of portfolio

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account